Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

CVRX


Fundamental

Company: CVRx Inc
Sector: Healthcare
Industry: Medical Devices
Country: USA
Exchange: Micro
Index: RUT
P/E: -
EPS (ttm): -2.01
Insider Own: 42.84%
Shs Outstand: 26.43M
Perf Week: -8.07%
Market Cap: 148.07M
Forward P/E: -
EPS next Y: -1.89
Insider Trans: 0.22%
Shs Float: 15.17M
Perf Month: -18.78%
Enterprise Value: 135.17M
PEG: -
EPS next Q: -0.52
Inst Own: 29.03%
Short Float: 12.56%
Perf Quarter: -31.62%
Income: -52.66M
P/S: 2.51
EPS this Y: 3.78%
Inst Trans: -1.80%
Short Ratio: 6.48
Perf Half Y: -44.14%
Sales: 59.07M
P/B: 5.07
EPS next Y Percentage: 3.49%
ROA: -45.93%
Short Interest: 1.91M
Perf YTD: -21.41%
Book/sh: 1.10
P/C: 2.05
EPS next 5Y: 6.49%
ROE: -106.96%
52W High: 11.30 -50.62%
Perf Year: -17.94%
Cash/sh: 2.72
P/FCF: -
EPS past 3/5Y: -0.43% -22.44%
ROIC: -59.74%
52W Low: 4.37 27.69%
Perf 3Y: -57.89%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: 36.11% 56.40%
Gross Margin: 84.87%
Volatility W: 6.36%
Volatility M: 9.44%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 2.29
EPS Y/Y TTM: 8.07%
Oper. Margin: -84.62%
ATR (14): 0.54
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 8.89
Sales Y/Y TTM: 11.73%
Profit Margin: -89.15%
RSI (14): 35.25
Recom: 1.57
Dividend Gr. 3/5Y: - -
Current Ratio: 10.20
EPS Q/Q: 6.43%
SMA20: -12.05%
Beta: 0.78
Target Price: 11.17
Payout: -
Debt/Eq: 2.04
Sales Q/Q: 19.61%
SMA50: -24.68%
Rel Volume: 0.55
Prev Close: 5.63
Employees: 223
LT Debt/Eq: 2.03
Earnings: May 11 AMC
SMA200: -29.23%
Avg Volume: 294.24K
Price: 5.58
IPO: Jun 30, 2021
Option/Short: Yes / Yes
EPS/Sales Surpr.: 0.85% 1.93%
Trades:
Volume: 162,418
Change: -0.89%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z
William Blair cuts CVRx stock rating on salesforce issues - Investing.com somewhat bearish
CVRX

Summary: CVRx Inc (NASDAQ:CVRX) was downgraded by William Blair from Outperform to Market Perform due to first-quarter sales falling short of expectations, leading to lower revenue guidance and internal salesforce issues impacting performance.

Full article
2024-05-01T17:35:02Z